Triclabendazole biotransformation and comparative diffusion of the parent drug and its oxidized metabolites into Fasciola hepatica

Author： Mottier L. Virkel G. Solana H. Alvarez L. Salles J. Lanusse C.

Publisher： Informa Healthcare

ISSN： 1366-5928

Source： Xenobiotica, Vol.34, Iss.11-12, 2004-11, pp. : 1043-1057

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biotransformation of chlorpropham (CIPC) in isolated rat hepatocytes and xenoestrogenic activity of CIPC and its metabolites by in vitro assays

By Nakagawa Y. Nakajima K. Suzuki T.

Xenobiotica, Vol. 34, Iss. 3, 2004-03 ,pp. : 257-272

Informa Healthcare

Access to resources Recommend Favorite

Biotransformation of the xanthine oxidase inhibitor BOF-4272 and its metabolites in the liver and by the intestinal flora in rat

By Naito S. Nishimura M.

Xenobiotica, Vol. 30, Iss. 1, 2000-01 ,pp. : 103-109

Informa Healthcare

Access to resources Recommend Favorite

Stability studies on the cathepsin L proteinase of the helminth parasite, Fasciola hepatica

By Dowd A.J. Dooley M. Fagain C. Dalton J.P.

Enzyme and Microbial Technology, Vol. 27, Iss. 8, 2000-11 ,pp. : 599-604

Elsevier

Access to resources Recommend Favorite

Comparative Induction of CYP1A1 Expression by Pyridine and Its Metabolites

By Iba M.M. Fung J. Giannone J.V. Okey A.B.

Archives of Biochemistry and Biophysics, Vol. 378, Iss. 2, 2000-06 ,pp. : 299-310

Elsevier

Access to resources Recommend Favorite

Microbial biotransformation: a tool for drug designing

By Pervaiz I. Ahmad S. Madni M. Ahmad H. Khaliq F.

Applied Biochemistry and Microbiology, Vol. 49, Iss. 5, 2013-09 ,pp. : 437-450

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite